The Efficacy of Duvelisib Monotherapy Following Disease Progression on Ofatumumab Monotherapy in Patients with Relapsed/Refractory CLL or SLL in the DUO™ Crossover Extension Study
- Bryone Kuss
- , Matthew S. Davids
- , Peter Hillmen
- , Carol Moreno
- , James Essell
- , Nicole Lamanna
- , Zsolt Nagy
- , Ulrich Jaeger
- , Constantine Tam
- , Stephan Stilgenbauer
- , Paolo Ghia
- , Julio Delgado
- , Diep Le
- , Brenda Jeglinksi
- , Marco Montillo
Research output: Contribution to journal › Meeting Abstract › peer-review